GW Pharmaceuticals (United Kingdom)

350 papers and 32.1k indexed citations i.

About

In recent decades, authors affiliated with GW Pharmaceuticals (United Kingdom) have published 350 papers, which have received a total of 32.1k indexed citations. Scholars at this organization have produced 167 papers in Pharmacology, 98 papers in Molecular Biology and 65 papers in Oncology on the topics of Cannabis and Cannabinoid Research (155 papers), Epilepsy research and treatment (41 papers) and DNA Repair Mechanisms (36 papers). Their work is cited by papers focused on Pharmacology (12.8k citations), Molecular Biology (12.7k citations) and Oncology (9.5k citations). Authors at GW Pharmaceuticals (United Kingdom) collaborate with scholars in United Kingdom, United States and Spain and have published in prestigious journals including Nature, Cell and New England Journal of Medicine. Some of GW Pharmaceuticals (United Kingdom)'s most productive authors include Ethan B. Russo, Graeme C.M. Smith, Stephen P. Jackson, Alan Ashworth, Andrew Tutt, Niall M.B. Martin, Mark J. O’Connor, Geoffrey W. Guy, John M. McPartland and Christopher J. Lord.

In The Last Decade

Fields of papers published by authors at GW Pharmaceuticals (United Kingdom)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with GW Pharmaceuticals (United Kingdom) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with GW Pharmaceuticals (United Kingdom) at the time of their publication.

Countries citing scholars working at GW Pharmaceuticals (United Kingdom)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at GW Pharmaceuticals (United Kingdom). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at GW Pharmaceuticals (United Kingdom) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites GW Pharmaceuticals (United Kingdom) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Breakdown of academic impact, for scholars at Isaac Newton Institute for Mathematical Sciences Breakdown of academic impact, for scholars at Ligand Pharmaceuticals (United States) Breakdown of academic impact, for scholars at Joslin Diabetes Center Breakdown of academic impact, for scholars at Institut des Sciences des Plantes de Montpellier Breakdown of academic impact, for scholars at Los Angeles Pierce College Breakdown of academic impact, for scholars at International Institute for Nanotechnology Breakdown of academic impact, for scholars at Pennsylvania Department of Education Breakdown of academic impact, for scholars at Regeneron (United States)
Rankless by CCL
2025